论文部分内容阅读
根据2006年8月ACC/AHA/ESC更新的房颤治疗指南,除了孤立性(Atrial Fibrillation,AF)或存在禁忌证外,其他所有AF患者均应使用抗栓药物预防血栓,该指南还推荐了一系列具体的卒中危险分层作为选择抗栓药物的标准:建议具备年龄≥75岁、高血压、心力衰竭、左室收缩功能受损(LVEF≤35%或左室短轴缩短率<25%)、糖尿病之中任一项的AF患者为血栓栓塞中危,选用阿司匹林(81～325mg/d)或华法林(INR 2.0～3.0)均可;具备既往血栓栓塞史(脑卒中
In addition to Atrial Fibrillation (AF) or contraindication, all AF patients should have antithrombotic prophylaxis against thrombus, as recommended by the ACC / AHA / ESC Update August 2006 guidelines for AF, which is also recommended A series of specific risk stratifications for stroke are the criteria of choice for antithrombotic drugs: It is recommended that patients with age 75 years or older have hypertension, heart failure, impaired left ventricular systolic function (LVEF ≤ 35% or LV shortening <25% ), Diabetic patients with AF in any of the risk of thromboembolism, the choice of aspirin (81 ~ 325mg / d) or warfarin (INR 2.0 ~ 3.0) can be; with a history of previous thromboembolism (stroke